BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38224823)

  • 1. Unraveling a novel hippo-associated immunological prognostic signature: The contribution of SERPINE1 in facilitating colorectal cancer progression via the notch signaling pathway.
    Su X; Wang X; Lai J; Mao S; Li H
    Genomics; 2024 Mar; 116(2):110794. PubMed ID: 38224823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
    Wang H; Wang W; Wang Z; Li X
    Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
    Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
    Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of basement membrane-related gene based on single-cell and bulk RNA sequencing data to predict prognosis and evaluate immune characteristics in colorectal cancer.
    Han J; Wang Q; Li S; Yang J; Qiu Z; Fu W
    Environ Toxicol; 2024 Jun; 39(6):3367-3380. PubMed ID: 38445432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel prognostic signature of immune-related genes for patients with colorectal cancer.
    Wang J; Yu S; Chen G; Kang M; Jin X; Huang Y; Lin L; Wu D; Wang L; Chen J
    J Cell Mol Med; 2020 Aug; 24(15):8491-8504. PubMed ID: 32564470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pyroptosis-related signature in colorectal cancer: exploring its prognostic value and immunological characteristics.
    Jiang P; Fan J; Huang S; Liu L; Bai M; Sun Q; Shen J; Zhang N; Liu D; Zhou N; Feng Y; Jiang J; Zhu J
    PeerJ; 2023; 11():e16631. PubMed ID: 38144182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Feng L; Li G; Li D; Duan G; Liu J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
    Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
    Comput Biol Med; 2023 Aug; 166():107432. PubMed ID: 37729701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer.
    Liu J; Yu F; Liu Z; Wang X; Li J
    Cancer Biother Radiopharm; 2022 Dec; 37(10):963-975. PubMed ID: 34551265
    [No Abstract]   [Full Text] [Related]  

  • 15. Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer.
    Wang L; Chen X; Zhang H; Hong L; Wang J; Shao L; Chen G; Wu J
    Front Immunol; 2022; 13():1014834. PubMed ID: 36389750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of the Glycolysis and Immune-related Gene Signature for Prognosis in Colorectal Cancer.
    Jiang M; Liu Y; Xu J; Xu Z; Ye T; Li S; Jiang C
    Anticancer Res; 2024 Jan; 44(1):117-131. PubMed ID: 38159970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation.
    Zhang D; Zhang JW; Xu H; Chen X; Gao Y; Jiang HG; Wang Y; Wu H; Yang L; Wang WB; Dai J; Xia L; Peng J; Zhou FX
    Mol Cancer; 2024 Apr; 23(1):70. PubMed ID: 38576002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constructing a Tregs-associated signature to predict the prognosis of colorectal cancer patients: A STROBE-compliant retrospective study.
    Ping G; Tian Y; Zhou Z
    Medicine (Baltimore); 2022 Nov; 101(47):e31382. PubMed ID: 36451426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer.
    Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y
    BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: a novel therapeutic target.
    Wang S; Pang L; Liu Z; Meng X
    BMC Cancer; 2021 Jul; 21(1):767. PubMed ID: 34215248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.